Skip to main content

Ingalls & Snyder LLC

SEC CIK
0001041885
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Ingalls & Snyder LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
316,680
Value
$28.7M
% of portfolio
0.8%
Quarters held
22
Since Q1 2021
Holdings of ABT by Ingalls & Snyder LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026316,680$28.7M0.8%+4,548+1.5%AddedHolders
Q1 2026312,132$32.0M1.1%+52,013+20.0%AddedHolders
Q4 2025260,119$32.6M1.2%−2,121−0.8%ReducedHolders
Q3 2025262,240$35.1M1.2%+11,861+4.7%AddedHolders
Q2 2025250,379$34.1M1.2%−5,570−2.2%ReducedHolders
Q1 2025255,949$34.0M1.1%+3,098+1.2%AddedHolders
Q4 2024252,851$28.6M1.1%+6,221+2.5%AddedHolders
Q3 2024246,630$28.1M1.1%−282−0.1%ReducedHolders
Q2 2024246,912$25.7M1.1%+55,152+28.8%AddedHolders
Q1 2024191,760$21.8M1.0%+2,731+1.4%AddedHolders
Q4 2023189,029$20.8M0.9%+34,586+22.4%AddedHolders
Q3 2023154,443$15.0M0.7%+86+0.1%AddedHolders
Q2 2023154,357$16.8M0.8%−1,184−0.8%ReducedHolders
Q1 2023155,541$15.8M0.8%−1,042−0.7%ReducedHolders
Q4 2022156,583$17.2M0.9%−1,127−0.7%ReducedHolders
Q3 2022157,710$15.3M0.9%−1,812−1.1%ReducedHolders
Q2 2022159,522$17.3M0.9%−5,137−3.1%ReducedHolders
Q1 2022164,659$19.5M0.9%−799−0.5%ReducedHolders
Q4 2021165,458$23.3M1.1%−13,691−7.6%ReducedHolders
Q3 2021179,149$21.2M1.0%−13,648−7.1%ReducedHolders
Q2 2021192,797$22.4M1.0%−3,840−2.0%ReducedHolders
Q1 2021196,637$23.6M1.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.